ArticleClinical drug investigation2024

Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan.

Teppei Hagino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.